Our findings indicate that SUL enhances GLT–1 expression in astrocytes, potentially increasing glutamate reuptake, reducing extracellular glutamate concentrations, and mitigating epilepsy-associated alterations. This evidence concerns the gene SLC1A2 and epilepsy.